Address:6445 Main St., Suite P21-341
Dr. Eric Bernicker is board certified by the American Board of Internal Medicine in medical oncology. He completed his medical training, a residency in internal medicine, and a fellowship in hematology at Baylor College of Medicine. He also completed a fellowship in medical oncology at MD Anderson Cancer Center. The goal of Dr. Bernicker’s practice is to make sure that his patients get the best available treatments in a compassionate environment.
Dr. Bernicker is the primary investigator for a number of cooperative group, industry-sponsored, and investigator-initiated trials looking at different novel therapies for lung cancer, including immunotherapy. His main clinical focus is on solid tumor oncology, specifically cancers that arise in the thorax such as lung cancer and mesothelioma. He is also interested in targeted therapy for specific mutations that can lead to more personalized treatments for patients battling cancer.
Dr. Bernicker is an assistant clinical professor of medicine at Weill Cornell Medicine, chairman of the Houston Methodist Hospital Cancer Performance Improvement Committee, and the liaison for the American Society of Clinical Oncology’s quality program, Quality Oncology Practice Initiative (QOPI). He is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the International Association for the Study of Lung Cancer. He sees patients at Houston Methodist Hospital.